Perrigo Company plc (PRGON.MX)

687.00 +1.00 (+0.15%) At close: 02:55PM CST

Perrigo Company plc

The Sharp Building
Hogan Place
Dublin D02 TY74
Ireland
353 1 709 4000
https://www.perrigo.com

Sector(s): 
Industry: 
Full-time employees: 9,140

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Patrick Lockwood-Taylor	President, CEO & Director	43.75M	N/A	N/A
Mr. Eduardo Guarita Bezerra	Executive VP & CFO	22.07M	N/A	1976
Mr. Ronald C. Janish	Chief Transformation Officer and Executive VP of Global Operations & Supply Chain	25.02M	N/A	1966
Mr. Svend Andersen	Executive VP & President of Consumer Self-Care International	20.43M	N/A	1962
Ms. Kyle L. Hanson	Special Counsel to the CEO and the Board & Interim General Counsel for Strategic Litigation	17.41M	N/A	1965
Mr. Shannon Hukill	Senior Director of Technical Operations	N/A	N/A	N/A
Ms. Alison Ives	Executive VP & Chief Scientific Officer	N/A	N/A	1981
Mr. Bradley Joseph	Vice President of Global Investor Relations & Corporate Communications	N/A	N/A	N/A
Mr. Todd W. Kingma	Interim EVP, General Counsel & Corporate Secretary	23.62M	N/A	1960
Ms. Mary Reilly-Brest	Director of Global Organizational and Human Resource Development	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.

Description

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Corporate governance

Perrigo Company plc’s ISS governance QualityScore as of 29 June 2024 is 1. The pillar scores are Audit: 5; Board: 1; Shareholder rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.